Physician profile
Levi D Grimm
NPI 1811407752
$383.06
in general payments reported to CMS, 2019-2025
12 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.51 · 2023: $81.84 · 2024: $86.90 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $81.12 | 2022-2025 | Vyepti |
| Abbvie INC. | $56.80 | 2023 | |
| Medtronic, INC. | $54.46 | 2024 | Venaseal |
| Novo Nordisk INC | $33.22 | 2024-2025 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $27.84 | 2022 | |
| Eisai INC. | $25.04 | 2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.78 | 2022 | |
| Novartis Pharmaceuticals Corporation | $19.12 | 2025 | |
| Amgen INC. | $19.08 | 2024 | Repatha, Otezla |
| Dexcom, INC. | $16.89 | 2022 | |
| Pfizer INC. | $14.89 | 2025 | |
| Lilly USA, LLC | $14.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Levi Grimm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.